BeStock  
Stocks › Biotechnology › ALMS

Alumis ALMS

US equityMarket cap rank #3572Biotechnology
$3.96 −$0.37 (-8.55%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $4.03 +1.77%
Open$4.24
Prev close$4.33
Day range$3.94 – $4.37
Volume1.79M
Market cap$514.09M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$1.91M-7.7% YoY
Operating profit-$99.08M+14.1% YoY
Net profit-$94.88M+14.3% YoY
Diluted EPS-$0.73+31.1% YoY
Free cash flow-$80.04M+27.8% YoY
Operating cash flow-$79.57M

Revenue, last 8 quarters

$0.0Dec '24$17.4MMar '25$2.7MJun '25$2.1MSep '25$1.9MDec '25$1.7MMar '26$1.7MJun '26$1.9MSep '26

Net profit, last 8 quarters

$-94.8MDec '24$-99.0MMar '25$59.3MJun '25$-110.8MSep '25$-92.9MDec '25$-93.1MMar '26$-142.2MJun '26$-94.9MSep '26

Diluted EPS by quarter

-1.74Dec '24-1.82Mar '250.77Jun '25-1.06Sep '25-0.94Dec '25-0.74Mar '26-1.11Jun '26-0.73Sep '26

Free cash flow by quarter

$-75.1MDec '24$-80.4MMar '25$-107.0MJun '25$-110.9MSep '25$-71.9MDec '25$-87.2MMar '26$-81.7MJun '26$-80.0MSep '26

Annual revenue

$0.0FY22$0.0FY23$0.0FY24$24.1MFY25

Profitability & balance sheet

Operating margin-5,538.9%
Net margin-5,844.5%
Return on equity-110.9%
Return on assets-86.6%
Return on invested capital-105.5%
Current ratio5.57
Liabilities / assets22.6%
Cash & investments$431.34M
Total debt$30.28M
Net cash (debt)$401.06M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $1.91M $1.66M $1.74M $24.05M $1.93M
Total Operating Revenue $1.91M $1.66M $1.74M $24.05M $1.93M
Operating Expense $100.98M $108.69M $100.15M $477.85M $98.37M
Selling and Admin Expenses $20.19M $23.36M $18.61M $91.86M $15.59M
-General & Admin Expense $20.19M $23.36M $18.61M $91.86M $15.59M
Research & Development $80.79M $85.34M $81.54M $386.00M $82.79M
Operating Profit -$99.08M -$107.03M -$98.41M -$453.80M -$96.45M
Net Non-Operating Interest Income (Expense) $4.30M $4.95M $5.35M $14.18M $3.55M
Non-Operating Interest Income $4.30M $4.95M $5.35M $14.18M $3.55M
Other Income (Expense) -$109,000.00 -$41.90M $7,000.00 $187.74M -$33,000.00
Special Income (Charges) $0.00 -$41.82M – $187.91M $0.00
-Less:Restructuring and Mergern & Acquisition $0.00 $0.00 – -$187.91M $0.00
-Less:Impairment of Capital Assets $0.00 $41.82M – – –
Other Non-Operating Income (Expenses) -$109,000.00 -$71,000.00 $7,000.00 -$169,000.00 -$33,000.00
Pretax Profit -$94.88M -$143.98M -$93.05M -$251.89M -$92.93M
Tax $0.00 -$1.76M – -$8.56M $0.00
Net Profit -$94.88M -$142.22M -$93.05M -$243.33M -$92.93M
Profit from Continuing Operations -$94.88M -$142.22M -$93.05M -$243.33M -$92.93M
Net Income to Parent Company -$94.88M -$142.22M -$93.05M -$243.33M -$92.93M
Net Income to Common Stockholders -$94.88M -$142.22M -$93.05M -$243.33M -$92.93M
Basic EPS -$0.73 -$1.11 -$0.74 -$2.86 -$0.94
Diluted EPS -$0.73 -$1.11 -$0.74 -$2.86 -$0.94

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $488.71M $560.62M $671.59M $411.94M $411.94M
Total Current Assets $442.59M $514.08M $532.41M $318.23M $318.23M
Cash and Cash Equivalents & Short-Term Investments $431.34M $502.29M $522.94M $308.50M $308.50M
-Cash and Cash Equivalents $57.69M $63.71M $63.89M $89.67M $89.67M
-Short Term Investments $373.65M $438.59M $459.06M $218.83M $218.83M
Receivables $3.18M $3.86M $2.73M $2.08M $2.08M
-Accrued Interest Receivable $1.87M $2.09M $2.23M $1.34M $1.34M
-Taxes Receivable $1.30M $1.05M $499,000.00 $740,000.00 $740,000.00
Prepaid Assets $6.91M $6.95M $5.99M $6.42M $6.42M
Restricted Cash $0.00 $0.00 $86,000.00 $82,000.00 $82,000.00
Other Current Assets $1.16M $978,000.00 $659,000.00 $1.14M $1.14M
Total Non-Current Assets $46.12M $46.53M $139.18M $93.71M $93.71M
Net PPE $33.17M $34.12M $33.49M $35.16M $35.16M
-Gross PPE $43.79M $43.85M $42.35M $43.15M $43.15M
-Accumulated Depreciation -$10.62M -$9.73M -$8.86M -$7.99M -$7.99M
Goodwill and Other Intangible Assets $9.14M $9.14M $50.96M $50.96M $50.96M
Other Non-Current Assets $3.82M $3.28M $8.13M $7.59M $7.59M
Total Liabilities $110.29M $108.46M $104.57M $110.64M $110.64M
Total Current Liabilities $79.41M $76.23M $70.90M $73.32M $73.32M
Payables $8.93M $12.80M $11.59M $10.11M $10.11M
-Accounts Payable $8.93M $12.80M $11.59M $10.11M $10.11M
Current Accrued Expenses $58.57M $51.94M $48.55M $56.84M $56.84M
Short-Term Debt and Capital Lease Obligation $5.03M $4.82M $4.44M $4.67M $4.67M
-Current Capital Lease Obligation $5.03M $4.82M $4.44M $4.67M $4.67M
Current Deferred Liabilities $6.88M $6.67M $6.33M $1.46M $1.46M
Total Non-Current Liabilities $30.88M $32.23M $33.66M $37.33M $37.33M
Long Term Debt and Capital Lease Obligation $30.28M $31.61M $31.22M $32.24M $32.24M
-Long Term Capital Lease Obligation $30.28M $31.61M $31.22M $32.24M $32.24M
Non-Current Deferred Liabilities $384,000.00 $383,000.00 $2.14M $4.75M $4.75M
Other Non-Current Liabilities $220,000.00 $239,000.00 $301,000.00 $330,000.00 $330,000.00
Total Equity $378.43M $452.16M $567.02M $301.30M $301.30M
Stockholders' Equity $378.43M $452.16M $567.02M $301.30M $301.30M
Capital Stock $13,000.00 $12,000.00 $12,000.00 $10,000.00 $10,000.00
-Common Stock $13,000.00 $12,000.00 $12,000.00 $10,000.00 $10,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.61B $1.59B $1.56B $1.20B $1.20B
Retained Earnings -$1.23B -$1.14B -$994.93M -$901.88M -$901.88M
Gains/Losses Not Affecting Retained Earnings -$730,000.00 -$683,000.00 -$467,000.00 $188,000.00 $188,000.00
-Other Receivables – $724,000.00 – – –
Investments and Advances – – $46.60M – –
-Available for Sale Securities – – $46.60M – –

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$79.57M -$81.50M -$87.08M -$369.52M -$71.91M
Net cash flow from continuing operations -$79.57M -$81.50M -$87.08M -$369.52M -$71.91M
Net Income from Continuing Operations -$94.88M -$142.22M -$93.05M -$243.33M -$92.93M
Depreciation & Depletion & Amortization $883,000.00 $874,000.00 $871,000.00 $3.50M $867,000.00
Other Non-Cash Items $526,000.00 $516,000.00 $575,000.00 -$186.21M $540,000.00
Change in Working Capital $1.13M $5.31M -$6.30M $17.76M $12.93M
-Change in Prepaid Assets -$188,000.00 -$1.76M $344,000.00 $28.70M $5.93M
-Change in Payables and Accrued Expense $2.76M $2.90M -$7.11M -$6.47M $6.18M
-Change in Other Current Assets -$532,000.00 $4.94M -$545,000.00 -$5.54M -$462,000.00
-Change in Other Current Liabilities -$1.12M -$1.11M -$1.25M -$3.01M -$845,000.00
-Change In Other Working Capital $208,000.00 $341,000.00 $2.26M $4.07M $2.13M
Net cash flow from investing $65.94M $68.69M -$285.69M $287.88M $95.01M
Net Cash Flow from Continuing Investing Activities $65.94M $68.69M -$285.69M $287.88M $95.01M
Net PPE Purchase and Sale -$464,000.00 -$237,000.00 -$164,000.00 -$653,000.00 $0.00
Net Investment Purchase and Sale $66.41M $68.93M -$285.52M $238.79M $95.01M
Financing Cash Flow $7.61M $12.63M $346.99M $2.07M $1.32M
Net Cash Flow from Continuing Financing Activities $7.61M $12.63M $346.99M $2.07M $1.32M
Net Common Stock Issuance -$1.57M $1.57M $323.80M $0.00 $0.00
Proceeds from Stock Option Exercised $9.18M $11.06M $23.19M $2.07M $1.32M
Ending Cash Balance $59.08M $65.09M $65.27M $91.05M $91.05M
Net Change in Cash -$6.02M -$179,000.00 -$25.78M -$79.58M $24.42M
Beginning Cash Balance $65.09M $65.27M $91.05M $170.63M $66.63M
Free Cash Flow -$80.04M -$81.74M -$87.25M -$370.18M -$71.91M
Net Other Investing Changes – – – $49.74M $0.00
Net Preferred Stock Issuance – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on ALMS.

Sign in to join the discussion.

Scroll to Top